Precision medicine Cancer Middle Aged Microfluidics Ovarian cancer Carcinoma Bladder cancer Oxidative stress Immune checkpoint inhibitors Recurrence Metabolism Homologous recombination Mitochondria Migration NSCLC Lung cancer Melanoma Humans Bevacizumab Epidemiology Cancer du sein Guidelines Macrophages Aging France Aged Prognostic factors Deep learning Epigenetics Genomics Hypoxia PET/CT Chemotherapy Overall survival Human Autophagy Dosimetry Inflammation Breast cancer Ionizing radiation Clinical trial Genetics Therapy Mortality DNA repair Cytoskeleton Targeted therapy Cell migration Lymphoma Prostate cancer Tumor Female Mutation Survival Medicine COVID-19 Transcription Tumor microenvironment Leukemia Hepatocellular carcinoma Biomarker Oncology Resistance Angiogenesis Head and neck cancer Biomarkers Male Radiomics Obesity Metastasis Quality of life Surgery Treatment Radiation therapy Radiotherapy Toxicity Neoplasms Artificial intelligence Colorectal cancer PET Mouse Liver P53 Animals Classification Gene expression Prognosis Apoptosis Actin Adult Glioblastoma Diagnosis Cervical cancer MRI Chromatin Immunotherapy Dendritic cells PARIS team Machine learning Radiothérapie